HEALTH● LOWSep 2 · Sep 2, 2026, 11:34 AM
Teva posts mid-stage trial win for celiac disease therapy developed with Royalty Pharma
Seeking Alpha Tech · global
Teva achieved a successful mid-stage clinical trial result for a celiac disease therapy developed in partnership with Royalty Pharma. This indicates progress in treating the condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoExperts call for cross-sector collaboration to implement One Health initiative in KarnatakaThe HinduHEALTH2h agoPAMI confirmed the list of hospitals and clinics where retirees can be treated in November 2026ClarínHEALTH2h agoHow does this fluoride-free toothpaste compare when it comes to oral health?NPR NewsHEALTH3h agoFrance recalls 7 million condoms across EU over STI and unintended pregnancy concernsEuroNews [en]